You may receive up to 8 cycles of chemotherapy treatment followed by 24 months of chemotherapy-based maintenance treatment. You may continue to take ponatinib alone in the post-maintenance period for as long as your doctor thinks it is in your best interest. You will no longer be able to take the study drugs if the disease gets worse, if intolerable side effects occur, or if you are unable to follow study directions.